Get in Touch

Healthcare Tech Report Names Padideh Kamali-Zare a Biotech Leader for Globally Valuable Achievements:  Unlocking New Data for Brain Health Monitoring

AI-Powered "Breakthrough" Early Detection Software for Alzheimer's Disease Puts Darmiyan CEO on Top 25 Women Leaders in Biotechnology List
Key Takeaways
  • Darmiyan CEO Padideh Kamali-Zare achievements are recognized among Top 25 Women Leaders in Biotech 2021 according to Healthcare Tech Outlook magazine's review. Biotech plays a critical role in the well-being of global society, HealthTech Report commented.
  • Her digital health company Darmiyan, best known for its AI-Powered BrainSee technology, which earned an FDA Breakthrough designation in May, also secured a finalist spot at UCSF Health Awards recently. Using standard, non-invasive clinical brain MRI, Darmiyan's BrainSee software can objectively measure brain health, including detecting Alzheimer’s disease at the early prodromal stage, enabling timely medical interventions and care planning.
  • For being a "visionary" leader seeking to change the landscape of Alzheimer's disease monitoring and treatment, Darmiyan CEO Padideh Kamali-Zare rose above hundreds of nominations and joined an illustrious ranking led by Samsung Biologics.

San Francisco: October 20, 2021 -- Today the Healthcare Technology Report picked Darmiyan CEO Padideh Kamali-Zare in its coveted list: Top 25 Women Leaders in Biotechnology of 2021.

Darmiyan, best known for its AI-Powered BrainSee technology that earned an FDA Breakthrough Designation in May, also was a 2021 finalist in UCSF’s Health Awards. Using standard, non-invasive clinical brain MRI, BrainSee can objectively measure brain health, including detecting Alzheimer’s disease at the early prodromal stage, enabling timely medical interventions and care planning. Early detection or rule-out of Alzheimer’s disease non-invasively (no injection or radiation) and affordably is nonexistent in the clinical market today.

Investigators from Stanford, HMRI, Washington University, Baycrest, UHN, Hamilton HHS and elsewhere in the US and Canada involved in BrainSee’s validation believe the software platform will fill a gap in the clinical field by extracting from MRIs insights, maps and grades of brain tissue health.

Editors wrote: "As we have seen in recent years and months, biotechnology plays a critical role in the well-being of our global society. With the COVID-19 pandemic shining a spotlight on the importance of life sciences, both private and public organizations are providing unprecedented levels of funding and support to companies in biotech space.

The accomplished women selected for this year's awards have distinguished themselves through their professional achievements and contributions to their organizations. "

Winner of the World Technology Award in the field of Biotechnology and an Adjunct Professor at Stanford Medical School Dr. Ahmad Salehi noted, "Padideh Kamali-Zare has developed into a visionary and supportive leader of a biotech company, Darmiyan, that is looking to change the landscape of Alzheimer's disease." Salehi, who is a Darmiyan scientific advisor added, "For diagnosis we are too dependent on subjective tests such as neuropsychology-based cognitive tests and invasive biomarker tests. The possibility to have BrainSee, a single brain modality that advises and informs the clinician about cognitive impairment, would be of great benefit to patients and their caregivers and likely senior living."

"Dr. Kamali-Zare has epitomized and embraced the culture of health innovation," longevity market guru Mary Furlong observed. "She and her team have developed a new, innovative and needed technology to predict the trajectory of age-related neurodegenerative disorders and enable both clinicians and neuroscience researchers to measure brain health."

Today Healthcare Tech Report placed Dr. Kamali-Zare among those "building new companies, women unlocking revolutionary ways to treat deadly diseases, and other top female executives who are helping their companies navigate market expansion, legal considerations, and brand awareness, among other areas." They selected for the list exceptional leaders based on hundreds of nominations and comprehensive analysis of professional milestones achieved, longevity in the biotech field and demonstrated domain expertise. Further research was conducted using a broad set of data including feedback from colleagues, industry influence, key company events milestones, previous honors and recognition, and numerous other metrics.

Darmiyan applauds the achievements of all the Top 25 Women Leaders in Biotechnology of 2021 who are listed here.



 
Darmiyan (based in San Francisco, CA) has created the first virtual microscope of brain tissue and earned FDA breakthrough status on its first medical device. The core technology is fine-tuned for the human brain and patented; it can be calibrated for other organs as well. Darmiyan was incorporated in September 2016 and backed by Y-Combinator (YC) in 2017. The Company’s awards include TEDMED Hive Innovator in 2018, CABHI Innovation Award in 2019, listed in 2020 Fortune 40 Under 40 healthcare CEO, 2021 UCSF Health Awards Finalist and 2021 Healthcare Tech Report’s Top 25 Women in Biotechnology. Darmiyan's 2020 seed funding round is led by the global pharmaceutical giant Eisai with participation of YC and IT-Farm.



Key Takeaways
  • Darmiyan CEO Padideh Kamali-Zare achievements are recognized among Top 25 Women Leaders in Biotech 2021 according to Healthcare Tech Outlook magazine's review. Biotech plays a critical role in the well-being of global society, HealthTech Report commented.
  • Her digital health company Darmiyan, best known for its AI-Powered BrainSee technology, which earned an FDA Breakthrough designation in May, also secured a finalist spot at UCSF Health Awards recently. Using standard, non-invasive clinical brain MRI, Darmiyan's BrainSee software can objectively measure brain health, including detecting Alzheimer’s disease at the early prodromal stage, enabling timely medical interventions and care planning.
  • For being a "visionary" leader seeking to change the landscape of Alzheimer's disease monitoring and treatment, Darmiyan CEO Padideh Kamali-Zare rose above hundreds of nominations and joined an illustrious ranking led by Samsung Biologics.
Media Gallery
Video Gallery
Darmiyan's One Minute Video Won a MedTech Innovator Award
Download
Quotes
I am honored to be recognized on the Top 25 Women Leaders in Biotechnology of 2021, a distinguished group of field trailblazers and trendsetters wi...
Padideh Kamali-ZareDarmiyan CEO and Co-Founder
Padideh Kamali-Zare has developed into a visionary and supportive leader of a biotech company, Darmiyan, that is looking to change the landscape ...
Ahmad Salehi, MD, PhDDarmiyan Scientific Advisor
Darmiyan CEO Padideh Kamali-Zare is leading a team making existing technology transformational. It's great to see them being recognized by Healthca...
Larry AtkinsBusiness Advisor
Related Bios
Padideh Kamali-Zare
CEO
View Full Bio>>
Ahmad Salehi, MD, PhD
Darmiyan Scientific Advisor
View Full Bio>>
Kaveh Vejdani
Chief Medical and Technology Officer
View Full Bio>>
Thomas Liebmann
Chief Scientific Officer
View Full Bio>>
Larry Atkins
Advisor
View Full Bio>>
Contacts
Ilyse Veron
ILYSE@DARMIYAN.COM
Chief of Communications/Head of US Strategic Partnerships